InvestorsHub Logo
Followers 0
Posts 32
Boards Moderated 0
Alias Born 05/18/2016

Re: bluelucky post# 34830

Friday, 05/11/2018 1:14:03 PM

Friday, May 11, 2018 1:14:03 PM

Post# of 38634
My best guess to the reason they haven’t & won’t partner Regabatin “any day now” is because they will want to wait until PODRAS studies are complete. Whether PODRAS is or isn’t ready to be incorporated in this version of Regabatin to be partnered for development later this year is a big variable in value and potential marketability of the product. Pending the outcome of PODRAS studies, they may have a different set of interested suitors to partner with, and surely the values and details of the partnership will vary.

This is just a guess upon considering the business environment behind such a deal. If you’re IPCI, you’re not going to give away the farm on such a potentially market disruptive technology just to have a partner to help you through, you’ll want top dollar. If you’re a potential suitor, you’re not going to give top dollar unless you’re sure you know what you’re getting into (referring to having the PODRAS studies completed).